Skip to content

Phase-resolved Optical Coherence Tomography study.

Phase-resolved Optical Coherence Tomography study. - PRO-study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41882
Enrollment
175
Registered
2015-09-03
Start date
2017-08-10
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical Retina Pathology and Glaucoma

Interventions

Doppler-OCT
Optical Coherence tomography
Polarisation sensitive OCT

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Healthy subjects, without any known ocular diseae / pathology, or general disesase known to influence retinal vessels and / or the neuroretina. Patients with an indication for FA and / or ICG angiography, in particular with wet Age related Macular Degeneration, Diabetic Retinopathy, Retinal vascular occlusions, Central Serous Chorioretinopathy. Patients with ocular hypertension or glaucoma. Age 18 years or older. Willing and able o sign informed consent

Exclusion criteria

Exclusion criteria: Ocular spherical equivalent > +5D or

Design outcomes

Primary

MeasureTime frame
Outcome parameter(s) PR-OCT Added value of PR-OCT compared to conventional procedure(s) Sensitivity / specificity detection of pathology compared to conventional procedure(s)

Secondary

MeasureTime frame
Outcome parameters PR-OCT • Duration of procedure • Quality of images • Patients* experience of comfort degree

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)